Abstract
(2015). Chondroitin sulfate proteoglycan 4 as a target for chimeric antigen receptor-based T-cell immunotherapy of solid tumors. Expert Opinion on Therapeutic Targets: Vol. 19, No. 10, pp. 1339-1350. doi: 10.1517/14728222.2015.1068759

This publication has 86 references indexed in Scilit: